Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial
Giulia Lanzolla, Elena Sabini, Marenza Leo, Francesca Menconi, Roberto Rocchi, Angela Tindara Sframeli, Paolo Piaggi, Marco Nardi, Claudio Marcocci, Michele Marinò
Topics & Concepts
MedicineGraves' ophthalmopathyAtorvastatinRegimenClinical endpointGraves' diseaseDiplopiaPopulationDyslipidemiaInternal medicineRandomized controlled trialSurgeryDiseaseEnvironmental healthOphthalmology and Eye DisordersVestibular and auditory disordersIgG4-Related and Inflammatory Diseases